GL3

CAS No. 60037-39-0

GL3( —— )

Catalog No. M24597 CAS No. 60037-39-0

GL3 encodes a bHLH protein that regulates trichome development in arabidopsis through interaction with GL1 and TTG1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 348 In Stock
5MG 202 In Stock
10MG 312 In Stock
25MG 471 In Stock
50MG 616 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GL3
  • Note
    Research use only, not for human use.
  • Brief Description
    GL3 encodes a bHLH protein that regulates trichome development in arabidopsis through interaction with GL1 and TTG1.
  • Description
    GL3 encodes a bHLH protein that regulates trichome development in arabidopsis through interaction with GL1 and TTG1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    60037-39-0
  • Formula Weight
    1073.02
  • Molecular Formula
    C48H64O27
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C/C=C/1\[C@@H](C(=CO[C@H]1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)OC)CC(=O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OCCC4=CC=C(C=C4)OC(=O)C[C@@H]\5C(=CO[C@H](/C5=C/C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C(=O)OC)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Participation of the Arabidopsis bHLH factor GL3 in trichome initiation regulatory events.Plant Physiol. 2007 Nov;145(3):736-46.
molnova catalog
related products
  • Glyasperin A

    Glyasperin A has cytotoxic properties against P-388 cells, its IC50 values being 6.0 microM.

  • Cholestenone

    4-Cholesten-3-one is an intestinal metabolite of Cholesterol. It shows an anti-obesity effect on animals.

  • Obinutuzumab/afutuzu...

    Obinutuzumab GA101) a novel glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.